Pharmafile Logo
Pharmafocus logo
Advanced Search

Ryvu Therapeutics appoints Justyna ลปรณล‚tek to management board

May 29, 2025
Medical Communications, Research and Development Oncology, Ryvu Therapeutics, chief people officer, human resources, management board, oncology

Ryvu Therapeutics has promoted Justyna ลปรณล‚tek, chief people officer, to its management board. The appointment reflects the companyโ€™s focus on …

Appointment
clinical_trial_3

Neogap receives approval to administer full dose in cell therapy trial for colorectal cancer

May 28, 2025
Research and Development Neogap, Oncology, Swedish Medical Products Agency, colorectal cancer

Neogap Therapeutics has received regulatory approval from the Swedish Medical Products Agency to administer the full dose of its investigational …

News
handshake

TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform

May 28, 2025
Mergers and Acquisitions Cell and Gene Therapy (CGT), Corporate, Juno GmbH, TQ Therapeutics, juno therapeutics

TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through a share purchase agreement. Juno …

News

UK Researcher Wins Prestigious IBSA Foundation Fellowship for Pioneering Dermatology Study

May 28, 2025
Medical Communications, Research and Development Dermatology, IBSA Foundation Fellowship, Institut Biochimique SA (IBSA), Masami Ando Kuri, Milan Italy, Wellcome Sanger Institute, dermatology

Masami Ando Kuri from the Wellcome Sanger Institute named one of six global winners of the 2024 IBSA Foundation Fellowships. …

News
Press release

Orientation Marketing appoints Sarah Darcy as sales operations executive

May 27, 2025
Marketing Services, Sales and Marketing Corporate, pharmaceutical marketing agency, sales operations executive

Orientation Marketing has announced the appointment of Sarah Darcy as sales operations executive. She joins the business-to-business (B2B) life sciencesย and …

Appointment
lab

The Royal Marsden launches AI radiology platform to revolutionise cancer care

May 27, 2025
Analytical & Laboratory Services, Market & Product Development, Medical Education, Research and Development AI, CARPL.ai., Institute of Cancer Research, NTT DATA, National Institute for Health and Care Research, Oncology, The Royal Marsden, oncology, radiology

The Royal Marsden, a world-leading cancer research centre, has launched a large-scale, AI-powered radiology platform designed to accelerate cancer detection …

News

MC2 Therapeutics appoints Trine Ahlgreen as new CEO

May 27, 2025
Research and Development, Sales and Marketing CEO, Corporate, MC2 Therapeutics, Skin, inflammatory skin conditions

MC2 Therapeutics, a Danish pharma company focused on topical therapies for inflammatory skin conditions, has appointed Trine Ahlgreen as CEO. …

Appointment
clinical_trials_2

Moderna doses first US patient in phase 1 trial of mRNA-4106 for solid tumours

May 23, 2025
Research and Development Moderna, Oncology, START Center for Cancer Research, US

The START Center for Cancer Research has dosed the first US participant in Modernaโ€™s phase 1 clinical trial evaluating mRNA-4106, …

News

NICE recommends treatment for chronic kidney disease, IgA nephropathy

May 23, 2025
Market & Product Development, Medical Communications, Research and Development IgA nephropathy, National Institute for Health and Care Excellence, Nephrology, kidney disease

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending CSL Viforโ€™s FILSPARI (sparsentan) for …

News
blood_test

CHMP issues positive opinion for Blenrep combinations in relapsed/refractory multiple myeloma

May 23, 2025
Market & Product Development, Medical Communications, Research and Development Blenrep, Committee for Medicinal Products for Human USE, European Medicines Agency, Oncology, multiple myeloma

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion …

News
handshake

Sanofi to acquire Vigil Neuroscience, adding Alzheimerโ€™s disease candidate to early-stage pipeline

May 23, 2025
Mergers and Acquisitions, Research and Development Alzheimer's disease, Neurology, Sanofi, Vigil Neuroscience, neurodegenerative diseases

Sanofi has announced an agreement to acquire Vigil Neuroscience, a biotech company focused on therapies for neurodegenerative diseases. The deal …

News

PL BioScience and DewCell sign LOI to Jointly Develop Artificial Human Platelets for Scalable, Animal-Free Cell Culture Media

May 23, 2025
Research and Development Animal-Free, Artificial Human Platelets, Corporate, DewCell, Haematology, Human Platelet Lysate, Letter of Intent, Oncology, PL Bioscience

PL BioScience and DewCell Biotherapeutics have signed a Letter of Intent (LOI) for the development and supply of artificial human …

News
Press release

Another Day Pharma announces successful Phase II trial results for BZ371A in post-prostatectomy erectile dysfunctionย 

May 22, 2025
Research and Development Another Day Pharma, Genito-Urinary system, clinical trial, erectile dysfunction, prostate cancer, prostatectomy

First-in-class therapeutic peptide BZ371A confirmed as effective and well-tolerated  20 May 2025. Another Day Pharma Ltd, a company developing innovative …

News
Press release

Tiakis Biotech appoints Christoph Schmidt to supervisory board

May 22, 2025
Research and Development Cardiology, Tiakis Biotech, cardiovascular diseases, pulmonary arterial hypertension

Tiakis Biotech has announced the appointment of Christoph Schmidt to its supervisory board. Based in Kiel, Germany, the clinical-stage biotech …

Appointment

NICE recommends Pfizerโ€™s new once-weekly treatment for haemophilia B on NHS

May 22, 2025
Market Access, Research and Development Haematology, Hympavzi, NHS, NICE, Pfizer, haemophilia B, marstacimab

Walton Oaks, 21stย May 2025ย โ€“ย Pfizer Ltd announced today that the National Institute for Health and Care Excellence (NICE) has published final …

News
Press release

Five Facts about mental health

May 21, 2025
Medical Communications, Medical Education, Research and Development European Commission, Pharmacy, Psychiatry, mental health, mental health condition

32% of people suffer from at least one mental health issue, with daily struggles like financial and job insecurity being …

Feature
researchers

Novartis releases new data across oncology and haematology pipelines

May 21, 2025
Research and Development ASCO, EHA, Haematology, Novartis, Oncology, oncology

Novartis has announced it will present new data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking …

News

Slingshot Therapeutics appoints Ed Savory as head of chemistry

May 21, 2025
Research and Development Corporate, Pharmacy, Slingshot Therapeutics, appointment

Slingshot Therapeutics has announced the appointment of Ed Savory as head of chemistry. He will oversee the companyโ€™s chemistry strategy …

Appointment

BioPhorum appointsย Uwe Buecheler as non-executive director

May 21, 2025
Medical Communications, Research and Development BioPhorum, Corporate, appointment, biopharma, medical communication

BioPhorum has announced the appointment of Uwe Buecheler as a non-executive director to its board. The company brings together leaders …

Appointment

Multiple myeloma treatment approved in Japan

May 21, 2025
Market Access, Research and Development, Sales and Marketing GSK, Japan, Oncology, Orphan Drug Designation (ODD), multiple myeloma

GSKโ€™s Blenrep (belantamab mafodotin) combinations have been approved by Japanโ€™s Ministry of Health, Labour and Welfare for the treatment of …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeuticsโ€™ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026